Press Releases: Page 2
Post a press release | Manage press releases
-
Canadian Alliance for Skills and Training in Life Sciences partners with British Columbia Institute of Technology on new Biomanufacturing Training Facility
Press release from CASTL • February 15, 2023 -
EUCOPE adds nine new innovative members to its network
Press release from EUCOPE - European Confederation of Pharmaceutical Entrepreneurs • February 15, 2023 -
Vial Announces the Addition of Dr. Rajat N Agrawal to their Ophthalmology CRO Scientific Advisory Board
Press release from Vial • February 14, 2023 -
Viz.ai Collaborates with Johns Hopkins to Expedite Patient Enrollment in Brain Injury Trial
Press release from Viz.ai • February 14, 2023 -
Vial Partners with Egnyte to Integrate Life Sciences eTMF Solution into Their Clinical Trial Platform
Press release from Vial • February 09, 2023 -
Leading Pharma & Life Sciences Executive Richard Peck Joins Adapt Ideations
Press release from Adapt Ideations • February 08, 2023 -
Ymmunobio Appoints Angela S. Gibbs as Chief Business Officer
Press release from Ymmunobio • February 08, 2023 -
Grant Awarded for Development of In Vitro Car-T Safety Assay
Press release from Testavec Ltd • February 03, 2023 -
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Press release from Fishawack Health • February 02, 2023 -
Vial CEO and Co-Founder, Simon Burns to Speak at the BIO CEO & Investor Conference in New York
Press release from Vial • January 30, 2023 -
Verisense Health, a Shimmer Research Spin-off, Launches as a Digital Health Software and Data Management Company
Press release from Verisense Health • January 30, 2023 -
iVexSol Closes $23.8M Series A-3 Financing
Press release from iVexSol, Inc. • January 26, 2023 -
Vial Partners with RecensMedical in Phase III Clinical Trial to Further Ophthalmology Innovations
Press release from Vial • January 25, 2023 -
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) announces location for Quebec Biomanufacturing Training Facility
Press release from CASTL • January 23, 2023 -
Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018-205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
Press release from Vial • January 19, 2023 -
New AAPS-RX Global Collaboration Produces 2-for-1 Registration Deal
Press release from American Association of Pharmaceutical Scientists • January 17, 2023 -
Vial Announces New Central Nervous System Scientific Advisory Board Member, Dr. Jacqueline French of the Epilepsy Study Consortium and NYU Grossman School of Medicine
Press release from Vial • January 12, 2023 -
Former Bayer Executive Jeff Owoc Joins Adapt Ideations
Press release from Adapt Ideations • January 11, 2023 -
The IMA Group Acquires Clinical Trials of America
Press release from The IMA Group • January 11, 2023 -
Sage Bionetworks Appoints New President
Press release from Sage Bionetworks • January 10, 2023
Previous
